Conditions: Diabetes Mellitus, Type 2
Keywords: Metabolic Diseases Glucose Metabolism Disorders Diabetes GLP-1 Lilly
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 145
Healthy volunteers: no

Brief summary:
The main purpose of this study is to assess dose-response characteristics in Japanese patients with Type 2 Diabetes taking LY2189265 monotherapy.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: LY2189265 intervention 2: Placebo
Intervention descriptions: intervention 1: Administered by subcutaneous (SC) injection, once weekly (QW) for 12 weeks. intervention 2: Administered by SC injection, QW for 12 weeks.

Protocol document: